Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...
The FDA banned the use of red dye No. 3 in foods and medicines sold in the U.S. because it has been shown to cause cancer in ...
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
Mesoblast winning approval for its Ryoncil ... having been knocked around by the FDA’s 2020 rejection of Ryoncil, requiring it to resubmit the drug. In August 2023 the company copped another ...
The key lies in adopting proven strategies that focus on sustainable lifestyle changes rather than quick fixes. A well-balanced diet combined with regular exercise and stress management are essential ...
The Food and Drug Administration (FDA) gave the green light ... in combination with a reduced-calorie diet and increased physical activity. “Today’s approval marks the first drug treatment ...
After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug Opdivo Qvantig’s average administration time of less than five minutes was observed in the Checkmate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback